Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

Clinical Genetics

Volumn 83, Issue 6, 2013, Pages 591-593

  Clendenning, M ^a   Macrae, Fa ^b   Walsh, Md ^a   Walters, R J ^a   Thibodeau, S N ^c   Gunawardena, S R ^c   Potter, J D ^d,e   Haile, R W ^f   Gallinger, S ^g   Hopper, J L ^h   Jenkins, M A ^h   Rosty, C ^a,i   Young, J P ^a   Buchanan, D D ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MAYO CLINIC   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e MASSEY UNIVERSITY   (New Zealand)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g MOUNT SINAI HOSPITAL   (Canada)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1;

CANCER REGISTRY; COLON; COLORECTAL CANCER; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA METHYLATION; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; REGISTRIES;

EID: 84876804457     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12011     Document Type: Letter

References (8)

1. Niessen RC, Kleibeuker JH, Westers H et al. PMS2 involvement in patients suspected of Lynch syndrome. Genes Chromosomes Cancer 2009: 48 (4): 322-329.
2. Umar A, Boland CR, Syngal S et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004: 96 (4): 261-268.
3. Senter L, Clendenning M, Sotamaa K et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008: 135 (2): 419-428.
4. Vaughn CP, Robles J, Swensen JJ et al. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes. Hum Mutat 2010: 31 (5): 588-593.
5. Clendenning M, Hampel H, LaJeunesse J et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 2006: 27 (5): 490-495.
6. van der Klift HM, Tops CM, Hes FJ et al. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome. Hum Mutat 2012: 33 (7): 1051-1055.
7. Morak M, Koehler U, Schackert HK et al. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J Med Genet 2011: 48 (8): 513-519.
8. Clendenning M, Buchanan DD, Walsh MD et al. Mutation deep within an intron of MSH2 causes Lynch syndrome. Fam Cancer 2011: 10 (2): 297-301.